U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07153172) titled 'Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108' on July 28.
Brief Summary: The study looks at the safety and blood levels of the study drug INV-347 in participants who were previously dosed with INV-347 in study INV-CL-108. Participants will not get any study drug in this study as it looks into the safety of a drug previously dosed. The study will last for about 2 years.
Study Start Date: Aug. 06
Study Type: INTERVENTIONAL
Condition:
Obesity
Intervention:
DRUG: INV-347
Participants who were dosed with INV-347 in the First In Human study INV-CL-108 and still have measurable plasma exposure of INV...